KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Alnylam Pharmaceuticals (ALNY) Gross Profit (2019 - 2026)

Alnylam Pharmaceuticals (ALNY) has disclosed Gross Profit for 8 consecutive years, with $959.7 million as the latest value for Q1 2026.

  • For Q1 2026, Gross Profit rose 2488.21% year-over-year to $959.7 million; the TTM value through Mar 2026 reached $3.5 billion, up 137.54%, while the annual FY2025 figure was $3.0 billion, 56.4% up from the prior year.
  • Gross Profit hit $959.7 million in Q1 2026 for Alnylam Pharmaceuticals, up from $829.3 million in the prior quarter.
  • Across five years, Gross Profit topped out at $1.1 billion in Q3 2025 and bottomed at -$40.2 million in Q1 2025.
  • Average Gross Profit over 5 years is $460.7 million, with a median of $418.9 million recorded in 2024.
  • Year-over-year, Gross Profit crashed 109.14% in 2025 and then surged 2488.21% in 2026.
  • Alnylam Pharmaceuticals' Gross Profit stood at $288.9 million in 2022, then increased by 27.31% to $367.7 million in 2023, then skyrocketed by 33.39% to $490.5 million in 2024, then soared by 69.07% to $829.3 million in 2025, then grew by 15.72% to $959.7 million in 2026.
  • According to Business Quant data, Gross Profit over the past three periods came in at $959.7 million, $829.3 million, and $1.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.